(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

IGF-1 LR3 Peptide Vial

IGF-1’s primary purpose is to promote the formation of new muscle tissue by enhancing protein synthesis and nitrogen retention. As a result, the peptide makes the muscle fibres larger and creates more of them. IGF-1 also has potent effects on fat metabolism, which accelerates fat burning. In addition, IGF1 LR3 also improves cognitive functions such as learning capacity and reflexes.

£20.85£89.35

Description

IGF-1 LR3 Peptide Vial New Zealand

IGF-1 LR3 (insulin-like growth factor-1 long arginine-3) is a synthetic insulin-like growth factor-1 derivative. Due to its poor affinity for IGF-1 binding proteins, IGF1 LR3 can remain active for up to 120 times longer than conventional IGF-1. A longer half-life for the peptide is the outcome, which increases activity. Increased hypertrophy muscle repair can be achieved by blocking myostatin, a vital component of this peptide supplementation. Recent studies reveal that IGF-1 LR3 peptide vial has the potential to help mothers with infants improve their breastfeeding.

The IGF-1 LR3 peptide vial New Zealand belongs to the peptide family with a similar size and structure to insulin, a hormone that, according to research, is highly anabolic and is released in the liver as peripheral tissues in response to GH. This process helps facilitate the development of new muscles.

According to studies, the major function of IGF-1 is to build new muscle tissues by promoting protein synthesis and nitrogen retention. In addition, IGF-1 is also known to have potent effects on fat metabolism, and this helps the body burn fats more rapidly and also enhances mental functions like learning ability and reflexes.

IGF-1 LR3 peptide vial New Zealand, according to scientists, is referred to as the long term analogue of the human IGF-1 particularly designed and specifically manufactured for the mammalian cell cultures and to support large-scale recombinant biopharmaceuticals manufacturing.

Benefits of IGF-1 LR3 Peptide Vial: New Zealand

  • New Zealand Research has revealed promotes fat burning
  • Has the ability to build new and strong muscle.
  • Stability and an extended half-life in culture offers time and cost-saving benefits
  • Studies have shown this peptide is a powerful variant, and is guaranteed to benefit individuals in many ways, particularly in their fitness.

Amino Acid Sequence: MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA.

Molecular formula: C400H625N111O115S9

References:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750484/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665094/

ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY

DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.

Additional information

size

0.1mg vial, 1mg vial, Kit: 0.1mg vial, syringes & bac water, Kit: 1mg vial, syringes & bac water

Certificates

IGF-1 LR3_Pharmagrade HPLC Certificate

You may also like…